CD34 and acute myeloid leukemia: Horiguchi et al. found that EV miRNA7977 derived from AML/MDS CD34+ cells, is transferred into BM-MSCs where it reduces the poly binding protein 1 levels by compromising their ability to support CD34+ cells [150].